Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

30 results about "Phosphorous pentachloride" patented technology

Internal circulation reactor and method for continuously preparing phosphorus pentafluoride

The invention discloses an internal circulation reactor and method for continuously preparing phosphorus pentafluoride. The internal circulation reactor comprises a cylinder body with a heat exchange jacket, wherein planar end closures are arranged at the upper and lower ends of the cylinder body, and a concentric inner cylinder body is arranged in the cylinder body; the upper end closure is provided with a mixed gas leading-out pipe; the lower end closure is provided with a three-way gas intake pipe; and a reaction solution eduction pipe and a feed liquid ingress pipe are arranged on the cylinder body. The process of preparing phosphorus pentafluoride comprises the following steps: blowing the reactor with an inert gas; creating a low temperature environment of the reactor with a refrigerant; adding a phosphorous pentachloride solution, anhydrous hydrogen fluoride and the inert gas to the reactor for reaction; and continuously leading out mixed gas containing phosphorus pentafluoride and part of a low-concentration phosphorous pentachloride solution, and at the same time continuously adding a phosphorous pentachloride concentrated solution, anhydrous hydrogen fluoride and the inert gas to realize continuous operation. The internal circulation reactor and method for continuously preparing phosphorus pentafluoride have the advantages that the concentration stability of reactants in the reactor can be maintained, and continuous production and automatic control of phosphorus pentafluoride are realized.
Owner:TIANJIN LONGER NEW MATERIAL SCI & TECH

Preparation method of trandolapril midbody (2S, 3aR, 7aS)-octahydro-1H-indole-2-carboxylic acid

The invention discloses a preparation method of trandolapril midbody (2S, 3aR, 7aS)-octahydro-1H-indole-2-carboxylic acid, and the preparation method comprises the following steps of: preparing 3-chlorine-2-amino-propionic acid methyl ester hydrochloride by using phosphorous pentachloride and dichloromethane; preparing 3-chlorine-2-acetyl amino-propionic acid methyl ester hydrochloride by using the 3-chlorine-2-amino-propionic acid methyl ester hydrochloride, methylbenzene and acetyl chloride; preparing 2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylic acid by using the 3-chlorine-2-acetyl amino-propionic acid methyl ester hydrochloride, DMF (Dimethyl Formamide) and 1-pyrrole cyclohexene; preparing (2S)-octahydro-1H-indole-2-methyl carboxylat by using the 2,3,4,5,6,7-hexahydro-1H-indole-2-carboxylic acid, methanol and palladium on carbon; preparing the (2S, 3aR, 7aS)-octahydro-1H-indole-2-carboxylic acid by using the (2S)-octahydro-1H-indole-2-methyl carboxylat and the methanol. Compared with the prior art, the preparation method of the trandolapril midbody (2S, 3aR, 7aS)-octahydro-1H-indole-2-carboxylic acid, which is disclosed by the invention, has the advantages of easiness and convenience for process, easiness for control, safety, reliability and low cost.
Owner:大连鼎燕医药化工有限公司 +1

Synthesis method of N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole

The invention discloses a synthesis method of N-cyclohexyl-5-(4-chlorobutyl)-1H-tetrazole. The synthesis method comprises the following steps: firstly, synthesizing N, N-dimethylformamide; the synthesis method comprises the following synthesis steps: taking 5-chlorovaleronitrile and cyclohexanol as raw materials, controlling the molar ratio of the 5-chlorovaleronitrile to the cyclohexanol to be (1: 1)-(1: 1.5) and the reaction temperature to be 5-55 DEG C, and carrying out a catalytic reaction for 1-6 hours by virtue of concentrated sulfuric acid, so as to obtain 5-chloro-N-cyclohexylvaleramide; wherein the molar ratio of the 5-chlorovaleronitrile to the concentrated sulfuric acid for catalysis is (1: 3)-(1: 10); the preparation method comprises the following steps: treating 1, 5-chloro-N-cyclohexylvaleric amide with phosphorus pentachloride; wherein the molar ratio of the 3, 5-chloro-N-cyclohexylvaleric amide to the phosphorus pentachloride is (1: 1)-(1: 1.5) and the molar ratio of the 2, 5-chloro-N-cyclohexylvaleric amide to the phosphorus pentachloride is (1: 1)-(1: 1.5); according to the invention, trimethyl silicon azide is used as a cyclization reagent instead of azoic acid or sodium azide, so that the synthesis method has the advantages of higher stability, no explosion and higher safety, the cost can be effectively reduced, the synthesis method is environment-friendly,and the purity of the obtained product is high.
Owner:上海立科化学科技有限公司

Production method of diacetyl monoxime

The invention discloses a production method of diacetyl monoxime, and relates to a method for producing diacetyl monoxime by reacting butanone with alkyl nitrite in a microtube reactor under the catalysis of a mixed catalyst system. . The method comprises the following steps: respectively adding premixed liquid of the catalyst and the butanone and the alkyl nitrite into the microtube reactor through a metering pump, wherein the mass ratio of the catalyst to the butanone is (0.1-0.2): 1, the molar ratio of the alkyl nitrite to the butanone is (1.01-1.1): 1, and the reaction pressure in the microtube reactor is 0.1-0.5 MPa, the reaction temperature is set to be 30-50 DEG C, the reaction time is 30-60 seconds and the catalyst is a mixture of concentrated hydrochloric acid, phosphorus pentachloride and concentrated phosphoric acid. The method has the beneficial effects that the moisture in the reaction system is reduced, the excessive use of raw materials is avoided, the production cost issaved, the production efficiency is improved and the pollution of excessive reactants to the environment is reduced and the reaction safety is improved; and the equipment investment is low, the occupied area is small and mass production is facilitated.
Owner:湖州柏特生物科技有限公司

Internal circulation reactor and method for continuously preparing phosphorus pentafluoride

The invention discloses an internal circulation reactor and method for continuously preparing phosphorus pentafluoride. The internal circulation reactor comprises a cylinder body with a heat exchange jacket, wherein planar end closures are arranged at the upper and lower ends of the cylinder body, and a concentric inner cylinder body is arranged in the cylinder body; the upper end closure is provided with a mixed gas leading-out pipe; the lower end closure is provided with a three-way gas intake pipe; and a reaction solution eduction pipe and a feed liquid ingress pipe are arranged on the cylinder body. The process of preparing phosphorus pentafluoride comprises the following steps: blowing the reactor with an inert gas; creating a low temperature environment of the reactor with a refrigerant; adding a phosphorous pentachloride solution, anhydrous hydrogen fluoride and the inert gas to the reactor for reaction; and continuously leading out mixed gas containing phosphorus pentafluoride and part of a low-concentration phosphorous pentachloride solution, and at the same time continuously adding a phosphorous pentachloride concentrated solution, anhydrous hydrogen fluoride and the inert gas to realize continuous operation. The internal circulation reactor and method for continuously preparing phosphorus pentafluoride have the advantages that the concentration stability of reactants in the reactor can be maintained, and continuous production and automatic control of phosphorus pentafluoride are realized.
Owner:TIANJIN LONGER NEW MATERIAL SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products